ASHP Calls on HHS to Halt Lilly’s 340B Data Cutoff
Editor's note: Updated 6/18 to reflect cut-off date not yet enacted, plus new comments from Jesse Dresser, Esq., of Frier LevittBy Gina ShawIn early June, Eli Lilly gave an initial group of 340B hospitals five business days to turn over detailed claims-level data or lose access to discounted drug pricing, and ASHP is urging federal regulators to step in before the deadline hit.As of mid-June, the threatened cutoff had not taken effect for many of the covered entities that received the notice, ev
Read more »
Pharmacy news
As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists
Omadacycline Trial Offers a Rare Win for NTM, While Shorter TB Treatment Regimens Are Limited by Toxicities
Rethinking Inpatient IV Default for PWID With Serious Injection-Related Infections
ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling
Pediatric Iron Deficiency: New Ferritin Thresholds, and a Wider Role for Pharmacy
IV Iron During Acute Infection Linked to Lower Mortality, Real-World Analysis Finds
Action Steps for Reimbursement Readiness
Emerging Therapies For Blood Cancers
ASHP Futures 2025: Medication Safety in the AI Era
A Plague on Patient Assistance
Decnupaz Approved for Blastic Plasmacytoid Dendritic Cell Neoplasms
ASHP Futures 2026: Proactive Tools to Modernize Medication Safety
As Manufacturers Catch On to Alternative Funding Programs, More Specialty Patients Routed to Overseas Pharmacies
Ambulatory Care Pharmacists Drive Higher Specialty Prescription Capture